Family Office Of America (FOFA) Research & Development (2021 - 2023)
Family Office Of America's (FOFA) quarterly Research & Development came in at $1500.0 in Q1 2023, down 87.67% year-on-year from $12167.0 in Q1 2022, and down 93.51% quarter-over-quarter from $23100.0 in Q4 2022.
Family Office Of America (FOFA) Research & Development (2021 - 2023) Analysis & Trends
Family Office Of America has disclosed Research & Development across 3 years of filings, most recently posting $1500.0 for Q1 2023.
- Research & Development for Q1 2023 came in at $1500.0, down 87.67% year-over-year; the trailing twelve-month figure through Dec 2023 was $1500.0 (down 98.14% YoY), and the FY2023 annual result was $1500.0, down 98.04% from the prior year.
- Research & Development came in at $1500.0 for Q1 2023 at Family Office Of America, down from $23100.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $128479.0 in Q2 2021 to a low of $1500.0 in Q1 2023.
- The 3-year median for Research & Development is $45418.0 (2022), against an average of $65333.1.
- Across the five-year window, Research & Development tumbled 64.65% in 2022 and tumbled 87.67% in 2023, its largest moves.
- Family Office Of America's Research & Development stood at $124734.0 in 2021, then sank by 81.48% to $23100.0 in 2022, then slumped by 93.51% to $1500.0 in 2023.
- The last three Research & Development figures came in at $1500.0 (Q1 2023), $23100.0 (Q4 2022), and $45418.0 (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Family Office Of America | - | - | 783,126.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 1,500.00 |
| Dec 31, 2022 | 23,100.00 |
| Jun 30, 2022 | 45,418.00 |
| Mar 31, 2022 | 12,167.00 |
| Dec 31, 2021 | 124,734.00 |
| Sep 30, 2021 | 121,934.00 |
| Jun 30, 2021 | 128,479.00 |